Gregory Bailey, Director at Serina Therapeutics, Inc. (SER), bought 6,400 shares at $7.07 ($45K) on 2024-08-14, disclosed to the SEC on 2024-08-16.
Open-market purchase of $45k SER by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade D.
Something here stands out, but not much.
| Filing → |
| BHVN | BUY | 2024-09-25 | $221K | — | Filing → |
| SER | BUY | 2024-09-24 | $7K | — | Filing → |
| SER | BUY | 2024-09-20 | $88K | — | Filing → |